Health
Common medicines could lead to cancer patients’ deaths – Ballina Shire Advocate
Cancer patients are more likely to die of their disease if they use common antacids bought at the chemist at the same time as immunotherapy treatments.
Cancer patients are more likely to die of their disease if they use common antacids at the same time as immunotherapies a groundbreaking Australian study has found.
Flinders University researchers found bladder cancer patients using antacids called proton pump inhibitors (PPIs) were more likely to have their cancer progress and were less likely to respond to the breakthrough immunotherapy cancer treatment atezolizumab than those not using antacids.
The reason is the antacids change the patient…
-
Business19 hours agoTop brokers name 3 ASX shares to buy next week 14 September 2025
-
Noosa News21 hours agoLord Howe Island detection dog Sebbi retires to Brisbane after years of ‘hard work’
-
Noosa News23 hours agoNoosa Reds: There’s something about tomatoes
-
Noosa News21 hours agoWorld-famous bee sanctuary on Kangaroo Island under threat from Varroa mite